26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
New Jersey has amended its Wage Payment Law (WPL) to require employers with at least 10 employees to...
Read More >
Seyfarth Synopsis: The Federal Deposit Insurance Corporation is accepting comments until March 16, 2...
Read More >
Almost everyone can remember a time when you asked permission to do something that your mother thoug...
Read More >
On September 3, 2019, U.S. Citizenship and Immigration Services (USCIS) announced a notice of propos...
Read More >
In the energy space, smaller companies are finding it harder to compete on their own and larger comp...
Read More >
Employee Was Unlawfully Harassed by Manager, Then Fired After He Complained, Federal Agency Charged ...
Read More >